Trials / Sponsors / GeNeuro SA
GeNeuro SA
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC S Post-COVID-19 Syndrome | Phase 2 | 2022-08-29 |
| Terminated | Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients Multiple Sclerosis, Relapsing-Remitting | Phase 2 | 2017-06-06 |
| Completed | Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS Multiple Sclerosis, Relapsing-Remitting | Phase 2 | 2016-04-01 |